- Home
- HRMY vs KLIC Comparison
HRMY vs KLIC Comparison
Compare HRMY & KLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- KLIC
- Stock Information
- Founded
- HRMY 2017
- KLIC 1951
- Country
- HRMY United States
- KLIC United States
- Employees
- HRMY N/A
- KLIC N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- KLIC Semiconductors
- Sector
- HRMY Health Care
- KLIC Technology
- Exchange
- HRMY Nasdaq
- KLIC Nasdaq
- Market Cap
- HRMY 1.9B
- KLIC 1.7B
- IPO Year
- HRMY 2020
- KLIC N/A
- Fundamental
- Price
- HRMY $26.87
- KLIC $39.86
- Analyst Decision
- HRMY Strong Buy
- KLIC Strong Buy
- Analyst Count
- HRMY 10
- KLIC 3
- Target Price
- HRMY $51.30
- KLIC $48.33
- AVG Volume (30 Days)
- HRMY 1.0M
- KLIC 510.3K
- Earning Date
- HRMY 10-28-2025
- KLIC 11-12-2025
- Dividend Yield
- HRMY N/A
- KLIC 2.05%
- EPS Growth
- HRMY 58.41
- KLIC N/A
- EPS
- HRMY 3.10
- KLIC 0.11
- Revenue
- HRMY $772,527,000.00
- KLIC $657,842,000.00
- Revenue This Year
- HRMY $19.94
- KLIC N/A
- Revenue Next Year
- HRMY $16.65
- KLIC $12.94
- P/E Ratio
- HRMY $8.72
- KLIC $364.14
- Revenue Growth
- HRMY 17.74
- KLIC N/A
- 52 Week Low
- HRMY $26.26
- KLIC $26.63
- 52 Week High
- HRMY $41.61
- KLIC $52.08
- Technical
- Relative Strength Index (RSI)
- HRMY 27.45
- KLIC 51.25
- Support Level
- HRMY $26.56
- KLIC $40.05
- Resistance Level
- HRMY $27.48
- KLIC $42.23
- Average True Range (ATR)
- HRMY 1.01
- KLIC 1.24
- MACD
- HRMY -0.25
- KLIC -0.26
- Stochastic Oscillator
- HRMY 8.99
- KLIC 9.05
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.